Information Provided By:
Fly News Breaks for April 4, 2016
PLX
Apr 4, 2016 | 07:10 EDT
Rodman & Renshaw analyst Raghuram Selvaraju started Protalix Bio Therapeutics with a Buy rating and $3.50 price target.
News For PLX From the Last 2 Days
There are no results for your query PLX